ISOFORMS P69 AND P100 OF 2',5'-OLIGOADENYLATE SYNTHETASE INDUCED DIFFERENTIALLY BY INTERFERONS INVIVO AND INVITRO

被引:40
作者
WITT, PL
MARIE, I
ROBERT, N
IRIZARRY, A
BORDEN, EC
HOVANESSIAN, AG
机构
[1] MED COLL WISCONSIN, DEPT MICROBIOL, MILWAUKEE, WI 53226 USA
[2] INST PASTEUR, CNRS, UA 1157, F-75724 PARIS 15, FRANCE
来源
JOURNAL OF INTERFERON RESEARCH | 1993年 / 13卷 / 01期
关键词
D O I
10.1089/jir.1993.13.17
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Four isoforms of 2',5'-oligoadenylate (2-5A) synthetase have been identified (40, 44, 69, and 100 kD). The 40- and 44-kD enzymes are encoded by the same gene, probably different from the genes encoding the larger isoforms. In this study, induction of the 100- and 69-KD (p100, p69) isoforms in different individuals and in different cell types was investigated after treatment with recombinant human interferons (IFN): IFN-alpha2, IFN-beta(ser), or IFN-gamma. The p69 and p100 isoforms were quantitated in cell extracts on Western blots using specific polyclonal antibodies, or their activity was measured after purification of cell extracts on immunoaffinity columns. The p69 and p100 isoforms were differentially induced in Daudi, fibroblast, and colon adenocarcinoma cells treated with IFNs. Considerable individual variations in both basal and induced levels of p69 and p100 were observed in peripheral blood mononuclear cells from normal donors cultured with IFNs in vitro, and from cancer patients treated with IFN-alpha2 or with IFN-beta(ser). These results demonstrate that the p69 and p100 isoforms are present in vivo in peripheral blood mononuclear cells and their level is increased following IFN administration. Furthermore, both the in vivo and in vitro observations indicate that the expression of these enzymes is specific to each cell type and varies among individuals.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 33 条
[1]   2-5A SYNTHETASE-ACTIVITY DOES NOT INCREASE IN INTERFERON-RESISTANT FRIEND-LEUKEMIA CELL VARIANTS TREATED WITH ALPHA-BETA-INTERFERON DESPITE THE PRESENCE OF HIGH-AFFINITY INTERFERON RECEPTOR-SITES [J].
AFFABRIS, E ;
ROMEO, G ;
BELARDELLI, F ;
JEMMA, C ;
MECHTI, N ;
GRESSER, I ;
ROSSI, GB .
VIROLOGY, 1983, 125 (02) :508-512
[2]  
BENECH P, 1985, NUCLEIC ACIDS RES, V13, P1267
[3]   STRUCTURE OF 2 FORMS OF THE INTERFERON-INDUCED (2-'-5-') OLIGO-A SYNTHETASE OF HUMAN-CELLS BASED ON CDNAS AND GENE-SEQUENCES [J].
BENECH, P ;
MORY, Y ;
REVEL, M ;
CHEBATH, J .
EMBO JOURNAL, 1985, 4 (09) :2249-2256
[4]  
BUFFETJANVRESSE C, 1984, P SOC EXP BIOL MED, V175, P169
[5]  
CHEBATH J, 1987, J BIOL CHEM, V262, P3852
[6]   INTERFERON-INDUCED ENHANCEMENT OF 2',5'-OLIGOADENYLATE SYNTHETASE IN MIDGUT CARCINOID-TUMORS [J].
GRANDER, D ;
OBERG, K ;
LUNDQVIST, ML ;
JANSON, ET ;
ERIKSSON, B ;
EINHORN, S .
LANCET, 1990, 336 (8711) :337-340
[7]   IDENTIFICATION OF 69-KD AND 100-KD FORMS OF 2-5A SYNTHETASE IN INTERFERON-TREATED HUMAN-CELLS BY SPECIFIC MONOCLONAL-ANTIBODIES [J].
HOVANESSIAN, AG ;
LAURENT, AG ;
CHEBATH, J ;
GALABRU, J ;
ROBERT, N ;
SVAB, J .
EMBO JOURNAL, 1987, 6 (05) :1273-1280
[8]  
HOVANESSIAN AG, 1988, J BIOL CHEM, V263, P4945
[9]   INTERFERON-INDUCED AND DOUBLE-STRANDED RNA-ACTIVATED ENZYMES - A SPECIFIC PROTEIN-KINASE AND 2',5'-OLIGOADENYLATE SYNTHETASES [J].
HOVANESSIAN, AG .
JOURNAL OF INTERFERON RESEARCH, 1991, 11 (04) :199-205
[10]   2-MOLECULAR WEIGHT FORMS OF HUMAN 2',5'-OLIGOADENYLATE SYNTHETASE HAVE DIFFERENT ACTIVATION REQUIREMENTS [J].
ILSON, DH ;
TORRENCE, PF ;
VILCEK, J .
JOURNAL OF INTERFERON RESEARCH, 1986, 6 (01) :5-12